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Human A431 cells express a 100 kDa EGF-receptor homolog that contains only the external domain. The kinetics of its maturation and export 
are slow and comparable to those of the transmembrane r ceptor. Here we demonstrate that exogenously added EGF stimulates post-translational 
processing and export of this receptor through a pathway that is insensitive to inhibitors of protein synthesis. The results suggest hat EGF may 
influence one or more of the rate dete~ining steps that control receptor export from endoplasmic reticulum. This may constitute one of the path- 
ways by which EGF regulates the expression of its receptor. 
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1. INTRODUCTION 
The epidermal growth factor (EGF)-receptor belongs 
to a group of transmembrane tyrosine kinases that in- 
cludes as its members the Nell protein and the receptors 
for insulin and insulin-like growth factors [l]. The ex- 
ternal domains of these proteins contain two structural 
features - the cysteine-rich regions and the sites for N- 
linked glycosylation - that are important from the view- 
point of post-translations maturation and extemaliza- 
tion to the cell surface [l-4]. In this paper we describe 
the processing and export characteristics of a secreted 
100 kDa homolog of EGF-receptor, which is identical 
to the external domain of the transmembrane receptor 
in its primary structure [5]. The results indicate that the 
processing and export characteristics of the soluble 
receptor are similar to those of the membrane anchored 
form. Moreover we find that EGF, the ligand, ac- 
celerates post-translational processing and secretion of 
the 100 kDa glycoprotein. These effects occur indepen- 
dent of any EGF-induced stimulation of receptor pro- 
tein synthesis. 
Western blotting was conducted as described using an EGF-receptor 
specific rabbit polyclonal antibody and ‘251-labelled protein A [6,71. 
Immunoprecipitation was conducted as described using a mouse 
monoclonal anti-EGF-receptor antibody [8,9]. 
3. RESULTS AND DISCUSSION 
3.1. EGF increases the steady state level of EGF- 
receptor in the medium 
The studies described here were conducted with 
human A431 cells - a cell type that expresses both the 
kinase active (EGF-responsive) transmembr~e 170 
kDa receptor and the kinase domain deficient secreted 
100 kDa homolog. The results in Fig. 1 show that ex- 
posure of cells to EGF results in increased accumulation 
of the 100 kDa receptor in the medium. This EGF- 
induced increase is blocked by monensin but not by 
chloroquine or cycloheximide. These results suggest 
that ongoing protein synthesis is not required for the ef- 
fect, i.e. the majority of the 100 kDa receptors released 
in response to EGF are pre-synthesized proteins block- 
ed in a pre-Golgi compartment. 
3.2. EGF enhances the secretion of pre-synthesized 
2. MATERIALS AND METHODS 
receptors 
A431 cells were grown as described in Bulbecco’s modified Eagle’s 
(DME)-medium containing 7% fetal bovine serum (FBS) [9,11]. 
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To dissociate the effect of EGF upon receptor 
maturation/export from its effects on receptor protein 
synthesis, pulse-chase studies were conducted. In these 
studies, cells were labelled with [3sS]met~o~ne for 1 h, 
then washed free of labelled proteins and incubated 
with unlabelled medium containing cycloheximide for 
different time periods (Fig. 2). Release of labelled 
receptor into the medium was analyzed by immuno- 
precipitation. The results show that there is time- 
dependent release of pre-synthesized labelled 100 kDa 
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Fig. 1. EGF increases the steady-state l vel of 100 kDa receptor in the 
medium. A431 ceils in 60 cm dishes were washed with serum-free 
DME-medium and then incubated at 37°C for 6 h with 3 ml of the 
same medium containing 20 nM EGF, 10 pg/ml cycloheximide 
(Chx.), 1OOrM chloroquine (Clq.), 1OpM monensin (Monen.), or no 
addition (Cont.). At the end of incubation, cellular media were sub- 
jected to Western blot analysis. 
receptor into the medium. The rate of release is slow 
(tl/z 14 h), but is enhanced in the presence of EGF (f1/2 
= 2 h) (Fig. 2). The EGF-induced effect was specific for 
the 100 kDa receptor, i.e. the rate of overall protein 
secretion (t1/2 = 1.5 h) was not significantly altered by 
EGF. 
3.3. Effects of glycosylation inhibitors on receptor 
export 
The appearance of labelled 100 kDa receptor in the 
medium is inhibited when tunicamycin [lo] is added 
during cell labelling, but not when it is added during 
chase (Fig. 3). Similar experiments with deoxyno- 
jirimycin [lo] showed that it inhibits labelled receptor 
export irrespective of whether it is added during label- 
ling or during chase (Fig. 3). In contrast, the presence 
of swainsonine [lo] during labelling or chase does not 
affect receptor export, only the product released is 
smaller than the fully processed glycoprotein (Fig. 3). 
Previous studies with the intact 170 kDa EGF recep- 
tor had indicated that both tunicamycin and deoxyno- 
jirimycin inhibit the exit of the protein from the en- 
doplasmic reticulum (ER) [1,3]. The results described 
here for the soluble receptor suggest hat the biosyn- 
thetic transport pathway of the isolated external do- 
main may not differ much from that of the intact recep- 
tor, despite the fact that the intact receptor is mem- 
brane-anchored and the 100 kDa receptor is free- 
floating in the lumen of ER. Overall the results in Fig. 3 
indicate that tunicamycin-sensitive core glycosylation 
of the 100 kDa receptor occurs soon after its entry into 
the lumen of ER, but the subsequent modifications 
(e.g. the deoxynojirimycin-sensitive processing within 
ER) which lead to its export from ER are slow and rate 
determining from the viewpoint of secretion. 
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Fig. 2. Effect of EGF on the time-course of secretion of pre- 
synthesized 100 kDa receptor. In three seperate experiments 
(O,A, q ), cells in 16 mm dishes were incubated for 1 h with 
[35S]methionine (100 &i/ml) as described [9], then chased at 37°C 
for the indicated times in the presence and absence of 20 nM EGF in 
DME-medium containing 0.1% bovine serum albumin and 10 ,ug/ml 
cycloheximide. Aliquots of cellular media were subjected to im- 
munoprecipitation and radiolabelled receptor was quantified by den- 
sitometric analysis of the autoradiograms (see panel A). Auto- 
radiogram for one of the experiments (A) is shown in panel B. Acid- 
precipitable radioactivity in media (overall protein secretion) deter- 
mined as described [9], showed no difference between control and 
EGF samples. 
3.4. EGF accelerates receptor processing 
Next we tested whether EGF accelerates the rate- 
determining events in receptor export. Cells were label- 
led with 3SS-methionine, then chased with unlabelled 
medium containing EGF or no EGF with deoxyno- 
jirimycin being added at various time points during 
chase. Since receptors that do not undergo the 
deoxynojirimycin-sensitive processing are not exported, 
the experiment in Fig. 4 provided a means for studying 
the time-course of this processing. The results show that 
the step is slow, but EGF accelerates it by 3-4-fold. 
Similar analysis was conducted for the swainsonine- 
sensitive event. The swainsonine-sensitive conversion of 
the high-mannose immature receptor to the mature 100 
kDa receptor was found to require = 4 h for completion 
in the absence of EGF, but only =2 h when EGF was 
present (data not shown). 
In previous studies we showed that EGF regulates 
syntheses and stabilities of EGF receptor mRNA and 
protein in A43 1 cells [9,1 I]. EGF also enhances the level 
of the 2.6 kb mRNA that encodes for the 100 kDa solu- 
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Fig. 3. Effect of glycosylation inhibitors on secretion of 100 kDa receptor. In experiments where inhibitors were present during cell labelling (lanes 
marked L), A431 cells were labelled with [“Slmethionine for 4 h in the presence (+ ) or absence (- ) of 1 &g/ml tunicamycin (Tunica), 4 mM deox- 
ynojirimycin (Nojiri), or 1.5 &ml swainsonine (Swain.), and then media were subjected to immunoprecipitation. In experiments where the in- 
hibitors were present during the chase (lanes marked C), cells were labelled with [“Slmethionine for 4 h, then washed, chased at 37°C for 11 h 
with DME-0.1 To BSA medium in the presence (+) or absence (- ) Bf the inhibitors, and then media were subjected to immunoprecipitation. 
ble EGF-receptor [l 11. The studies described here sug- 
gest that exogenously added EGF may exert receptor 
regulation at yet another level - the level of post- 
translational maturation and export. With respect to 
the pathway of EGF action we considered the possibili- 
ty of C-kinase, which is known to be involved in recep- 
tor regulation at pre-translational levels [ 121. However 
this kinase appears to have no direct involvement in 
post-translational receptor expression as seen by the in- 
ability of TPA to modulate this process (data not 
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Fig. 4. EGF stimulates the deoxynojirimycin-sensitive processing event. CelIs in 16 mm dishes were labelled with [‘?S]methionine for 2 h, then chas- 
ed at 37°C for 12 h in 0.3 ml of Dh%E-0.1% BSA containing 20 nM EGF or no EGF. ~xynojirimycin (4 mM) was added at the indicated time 
points of chase. All cellular media were collected at 12 h and subjected to immunoprecipitation. (A) Autoradiographic depiction of results; (B) 
plot of the densitometric data. The results are representative of three seperate xperiments. 
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shown). On the other hand the lack of inhibition by 
cycloheximide indicates that the EGF effect requires no 
new protein synthesis. It remains to be seen what EGF- 
induced cellular signalling pathways are involved in this 
soluble receptor export system, and whether EGF also 
modulates the post-translational transport character- 
istics of the intact transmembrane EGF-receptor. 
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